Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Riei Kamo"'
Publikováno v:
Skin Cancer. 37:22-26
Autor:
Masahiko Ohsawa, Daisuke Hayashi, Daisuke Tsuruta, Nao Kusutani, Riei Kamo, Hirokazu Nakahara
Publikováno v:
Skin Cancer. 35:58-64
Autor:
Eriko Hayashi, Riei Kamo, Keisuke Goto, Daisuke Hayashi, Masahiko Ohsawa, Junko Sowa-Osako, Daisuke Tsuruta, Nao Kusutani
Publikováno v:
The Journal of Dermatology. 48
Autor:
Riei Kamo, Daisuke Tsuruta, Ayaka Okazaki, Paul Nghiem, Kotaro Nagase, Yoshie Fukunaga, Nao Kusutani, Kozo Nakai
Publikováno v:
Dermatol Ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6689f4212d2f3e1abd945b414a55cf7
https://europepmc.org/articles/PMC9440151/
https://europepmc.org/articles/PMC9440151/
Publikováno v:
The Journal of Dermatology. 48
Publikováno v:
Dermatologic therapy. 33(6)
Autor:
Isao Oze, Shuhei Imayama, Toshiharu Fujiyama, Satoshi Hirakawa, Hiroaki Yagi, Masahiro Takigawa, Keitaro Matsuo, Taisuke Ito, Ryosuke Hino, Yoshiki Tokura, Hideo Hashizume, Riei Kamo
Publikováno v:
Journal of Dermatological Science. 75:43-48
Background Malignant melanoma (MM) often shows multiple chemo-resistance, leading to poor prognosis of the patients. Therapeutic anti-cancer vaccination may be a feasible way to prolong the survival of patients. We have demonstrated that application
Autor:
Reina Omura, Ryouko Awazawa, Kazuyoshi Fukai, Riei Kamo, Toshiyuki Ozawa, Nao Kusutani, Masahiko Osawa, Daisuke Tsuruta
Publikováno v:
The Journal of Dermatology. 46:e180-e181
Publikováno v:
Clinical and Experimental Dermatology. 37:749-752
Summary The prognosis of angiosarcoma remains very poor, even with combined, multimodal therapy. We report a case with partial response of angiosarcoma of the scalp to sorafenib, which is a new oral, molecular, targeted, multiple-kinase inhibitor. In
Publikováno v:
The Journal of Dermatology. 44:e344-e345